X-134852859-T-G

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_001388447.1(PABIR3):​c.649T>G​(p.Ser217Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000281 in 1,138,526 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 8 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000027 ( 0 hom., 1 hem., cov: 23)
Exomes 𝑓: 0.000028 ( 0 hom. 7 hem. )

Consequence

PABIR3
NM_001388447.1 missense

Scores

3
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.705

Publications

1 publications found
Variant links:
Genes affected
PABIR3 (HGNC:25202): (PABIR family member 3) Predicted to enable protein serine/threonine phosphatase inhibitor activity. Predicted to be involved in negative regulation of catalytic activity. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.073465794).
BS2
High Hemizygotes in GnomAdExome4 at 7 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PABIR3NM_001388447.1 linkc.649T>G p.Ser217Ala missense_variant Exon 10 of 11 ENST00000645433.2 NP_001375376.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PABIR3ENST00000645433.2 linkc.649T>G p.Ser217Ala missense_variant Exon 10 of 11 NM_001388447.1 ENSP00000496338.1 A0A2R8Y7S4

Frequencies

GnomAD3 genomes
AF:
0.0000268
AC:
3
AN:
111875
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000376
Gnomad OTH
AF:
0.000665
GnomAD2 exomes
AF:
0.0000114
AC:
1
AN:
87600
AF XY:
0.0000414
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000269
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000282
AC:
29
AN:
1026651
Hom.:
0
Cov.:
26
AF XY:
0.0000213
AC XY:
7
AN XY:
328641
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
24265
American (AMR)
AF:
0.0000401
AC:
1
AN:
24953
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
18269
East Asian (EAS)
AF:
0.00
AC:
0
AN:
26315
South Asian (SAS)
AF:
0.00
AC:
0
AN:
46025
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
26574
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4040
European-Non Finnish (NFE)
AF:
0.0000320
AC:
26
AN:
812468
Other (OTH)
AF:
0.0000457
AC:
2
AN:
43742
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.455
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000268
AC:
3
AN:
111875
Hom.:
0
Cov.:
23
AF XY:
0.0000294
AC XY:
1
AN XY:
34013
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30797
American (AMR)
AF:
0.00
AC:
0
AN:
10447
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2648
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3602
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2725
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5969
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
238
European-Non Finnish (NFE)
AF:
0.0000376
AC:
2
AN:
53260
Other (OTH)
AF:
0.000665
AC:
1
AN:
1504
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000285
Hom.:
1
Bravo
AF:
0.0000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Dec 27, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.405T>G (p.F135L) alteration is located in exon 6 (coding exon 6) of the FAM122C gene. This alteration results from a T to G substitution at nucleotide position 405, causing the phenylalanine (F) at amino acid position 135 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.59
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.63
CADD
Benign
7.3
DANN
Benign
0.95
DEOGEN2
Benign
0.017
T
FATHMM_MKL
Benign
0.084
N
LIST_S2
Benign
0.28
T
M_CAP
Benign
0.0026
T
MetaRNN
Benign
0.073
T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
0.34
N
PhyloP100
-0.70
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-1.5
N
REVEL
Benign
0.039
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
0.011
B
Vest4
0.26
MutPred
0.39
Loss of sheet (P = 0.0181);
MVP
0.60
MPC
0.18
ClinPred
0.084
T
GERP RS
0.70
Varity_R
0.26
gMVP
0.091
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1412745325; hg19: chrX-133986889; API